Tandem Diabetes Care | TNDM - Cost Of Sales


Tandem Diabetes Care reported $109.78M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 298.76M 4.74M Jun/2026
AtriCure USD 34.98M 3.04M Jun/2026
Baxter International USD 1.93B 118M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
Cooper Companies USD 401.3M 7.5M Jun/2026
Dexcom USD 478.4M 36.8M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Eli Lilly USD 3.27B 309M Jun/2026
Globus Medical USD 271M 7.41M Jun/2026
ICU Medical USD 316.63M 7.37M Jun/2026
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 239.1M 6.4M Jun/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
J&J USD 8B 67M Jun/2026
Medtronic USD 3.83B 26M Jun/2026
Merit Medical Systems USD 203.68M 6.6M Jun/2026
Orthofix International USD 66.63M 6.4M Dec/2025
Roche Holding CHF 7.85B 630M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Tandem Diabetes Care USD 109.78M 653K Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026